A multicentre, randomized, double-blind, placebo-controlled study to evaluate the efficacy, tolerability and safety of two doses of metrifonate in patients with mild-to-moderate Alzheimer's disease: the MALT study.
Source: International Journal of Geriatric Psychiatry 14(11):973-82.
Abstract: Available at PubMed
Institution: Hopital de la Pitie-Salpetriere, Paris, France. email@example.com
Subject headings: Abstracts, Alzheimer's disease, Daily living, Diagnosis, Drugs, Evaluation, Medical treatment, Older adults, Outcome, Psychological aspects, Psychological evaluation, Research methodology, Therapy